Hughes-Wilson Alexandra

Track

Insider profile

Performance

Overall performance
2.2
Performance over holding periods
2.2
30 days 90 days 120 days
Average return -14% 8.2% 15.1%
Success rate 20% 68% 82%
Transactions
8 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Hughes-Wilson Alexandra's trades of Mereo BioPharma Group PLC's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
5.42
Quantity 1,650
Value US$8,943
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-16 2024-09-13
S Sale
52,159 +22.8%
216.33
US$82,846 		52,159 +22.8% 216.33 US$82,846
2024-09-16 2024-09-13
S Sale
97,786 -8.9%
255.74
US$3,632,857 		97,786 -8.9% 255.74 US$3,632,857
2024-09-16 2024-09-12
S Sale
57,239 -34.8%
442.55
US$80,422 		57,239 -34.8% 442.55 US$80,422
2024-09-16 2024-09-12
S Sale
7,769 -3.9%
4.47
US$34,748 		7,769 -3.9% 4.47 US$34,748
2024-09-12 2024-09-12
PrS Proposed sale
148,110
4.66
US$690,193 		148,110 4.66 US$690,193
2024-06-27 2024-06-26
S Sale
22,968 -39.9%
3.39
US$77,935 		22,968 -39.9% 3.39 US$77,935
2024-06-27 2024-06-25
S Sale
10,134 -15.0%
3.69
US$37,434 		10,134 -15.0% 3.69 US$37,434
2024-06-24 2024-06-25
PrS Proposed sale
33,102
3.98
US$131,746 		33,102 3.98 US$131,746
2024-06-20 2024-06-21
PrS Proposed sale
33,102
3.98
US$131,746 		33,102 3.98 US$131,746
2024-05-23 2024-05-22
PrS Proposed sale
100,432
2.96
US$297,506 		100,432 2.96 US$297,506
2024-05-23 2024-05-22
S Sale
50,082 -60.6%
2.94
US$147,241 		50,082 -60.6% 2.94 US$147,241
2024-05-23 2024-05-22
S Sale
50,350 -46.2%
2.99
US$150,546 		50,350 -46.2% 2.99 US$150,546
2019-05-22 2019-05-20
B Purchase
1,650
5.42
US$8,943 		1,650 5.42 US$8,943